Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016 (2016), Article ID 4097574, 8 pages
http://dx.doi.org/10.1155/2016/4097574
Research Article

MMP8 Is Increased in Lesions and Blood of Acne Inversa Patients: A Potential Link to Skin Destruction and Metabolic Alterations

1Interdisciplinary Group of Molecular Immunopathology, Dermatology/Medical Immunology, University Hospital Charité, Berlin, Germany
2Psoriasis Research and Treatment Center, University Hospital Charité, Berlin, Germany
3Berlin-Brandenburg Center for Regenerative Therapies, University Hospital Charité, Berlin, Germany
4Department of Dermatology and Allergy, University Hospital Charité, Berlin, Germany
5Institute of Medical Immunology, University Hospital Charité, Berlin, Germany
6Research Center Immunosciences, University Hospital Charité, Berlin, Germany

Received 25 May 2016; Accepted 4 September 2016

Academic Editor: Giuseppe Valacchi

Copyright © 2016 Athanasia Tsaousi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. B. E. Jemec, “Clinical practice. Hidradenitis suppurativa,” The New England Journal of Medicine, vol. 366, no. 2, pp. 158–164, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. H. H. van der Zee, J. D. Laman, J. Boer, and E. P. Prens, “Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments,” Experimental Dermatology, vol. 21, no. 10, pp. 735–739, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. Ł. Matusiak, A. Bieniek, and J. C. Szepietowski, “Hidradenitis suppurativa markedly decreases quality of life and professional activity,” Journal of the American Academy of Dermatology, vol. 62, no. 4, pp. 706–708.e1, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. B. G. Vazquez, A. Alikhan, A. L. Weaver, D. A. Wetter, and M. D. Davis, “Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota,” Journal of Investigative Dermatology, vol. 133, no. 1, pp. 97–103, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Kurek, E. M. Johanne Peters, R. Sabat, W. Sterry, and S. Schneider-Burrus, “Depression is a frequent co-morbidity in patients with acne inversa,” Journal of the German Society of Dermatology, vol. 11, no. 8, pp. 743–750, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Kurek, E. M. J. Peters, A. Chanwangpong, R. Sabat, W. Sterry, and S. Schneider-Burrus, “Profound disturbances of sexual health in patients with acne inversa,” Journal of the American Academy of Dermatology, vol. 67, no. 3, pp. 422–e1, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Sabat, A. Chanwangpong, S. Schneider-Burrus et al., “Increased prevalence of metabolic syndrome in patients with acne inversa,” PLoS ONE, vol. 7, no. 2, Article ID e31810, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Tzellos, C. C. Zouboulis, W. Gulliver, A. D. Cohen, P. Wolkenstein, and G. B. E. Jemec, “Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies,” British Journal of Dermatology, vol. 173, no. 5, pp. 1142–1155, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. G. B. E. Jemec and A. B. Kimball, “Hidradenitis suppurativa: epidemiology and scope of the problem,” Journal of the American Academy of Dermatology, vol. 73, no. 5, supplement 1, pp. S4–S7, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. M. V. Laffert, P. Helmbold, J. Wohlrab, E. Fiedler, V. Stadie, and W. C. Marsch, “Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis,” Experimental Dermatology, vol. 19, no. 6, pp. 533–537, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Wolk, K. Warszawska, C. Hoeflich et al., “Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa,” The Journal of Immunology, vol. 186, no. 2, pp. 1228–1239, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Kryczka and J. Boncela, “Leukocytes: the double-edged sword in fibrosis,” Mediators of Inflammation, vol. 2015, Article ID 652035, 10 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. H. J. Hurley, “Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus,” in Dermatologic Surgery, R. H. Roegnick and H. H. Roegnick, Eds., pp. 717–743, Marcel Dekker, New York, NY, USA, 1989. View at Google Scholar
  14. K. Sartorius, J. Lapins, L. Emtestam, and G. B. E. Jemec, “Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa,” British Journal of Dermatology, vol. 149, no. 1, pp. 211–213, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Revuz, “Modifications to the Sartorius score and instructions for evaluating the severity of suppurative hidradenitis,” Annales de Dermatologie et de Venereologie, vol. 134, no. 2, pp. 173–174, 2007. View at Google Scholar · View at Scopus
  16. K. Sartorius, L. Emtestam, G. B. E. Jemec, and J. Lapins, “Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity,” British Journal of Dermatology, vol. 161, no. 4, pp. 831–839, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Wolk, S. Kunz, E. Witte, M. Friedrich, K. Asadullah, and R. Sabat, “IL-22 increases the innate immunity of tissues,” Immunity, vol. 21, no. 2, pp. 241–254, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Wolk, K. Witte, E. Witte et al., “IL-29 is produced by T(H)17 cells and mediates the cutaneous antiviral competence in psoriasis,” Science Translational Medicine, vol. 5, no. 204, Article ID 204ra129, 2013. View at Google Scholar
  19. E. Witte, G. Kokolakis, K. Witte et al., “Interleukin-29 induces epithelial production of CXCR3A ligands and T-cell infiltration,” Journal of Molecular Medicine, vol. 94, no. 4, pp. 391–400, 2016. View at Publisher · View at Google Scholar
  20. K. Wolk, H. Mitsui, K. Witte et al., “Deficient cutaneous antibacterial competence in cutaneous T-cell lymphomas: role of Th2-mediated biased Th17 function,” Clinical Cancer Research, vol. 20, no. 21, pp. 5507–5516, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Dejonckheere, R. E. Vandenbroucke, and C. Libert, “Matrix metalloproteinase8 has a central role in inflammatory disorders and cancer progression,” Cytokine and Growth Factor Reviews, vol. 22, no. 2, pp. 73–81, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Witte, G. Kokolakis, K. Witte et al., “IL-19 is a component of the pathogenetic IL-23/IL-17 cascade in psoriasis,” Journal of Investigative Dermatology, vol. 134, no. 11, pp. 2757–2767, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Khokha, A. Murthy, and A. Weiss, “Metalloproteinases and their natural inhibitors in inflammation and immunity,” Nature Reviews Immunology, vol. 13, no. 9, pp. 649–665, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. C. W. M. Ong, P. T. Elkington, S. Brilha et al., “Neutrophil-derived MMP-8 drives AMPK-dependent matrix destruction in human pulmonary tuberculosis,” PLoS Pathogens, vol. 11, no. 5, Article ID e1004917, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Salminen, P. Åström, J. Metso et al., “Matrix metalloproteinase 8 degrades apolipoprotein A-I and reduces its cholesterol efflux capacity,” The FASEB Journal, vol. 29, no. 4, pp. 1435–1445, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Silswal, A. K. Singh, B. Aruna, S. Mukhopadhyay, S. Ghosh, and N. Z. Ehtesham, “Human resistin stimulates the pro-inflammatory cytokines TNF-α and IL-12 in macrophages by NF-κB-dependent pathway,” Biochemical and Biophysical Research Communications, vol. 334, no. 4, pp. 1092–1101, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Cho, S.-E. Lee, H.-C. Lee et al., “Adipokine resistin is a key player to modulate monocytes, endothelial cells, and smooth muscle cells, leading to progression of atherosclerosis in rabbit carotid artery,” Journal of the American College of Cardiology, vol. 57, no. 1, pp. 99–109, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Parolini, A. Santoro, E. Marcenaro et al., “The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues,” Blood, vol. 109, no. 9, pp. 3625–3632, 2007. View at Publisher · View at Google Scholar · View at Scopus